(1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine

C150H189F3N32O9 — CID 159944945

IUPAC(1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine
SMILESCC1=CCc2ncc(-c3cn(C45CC(N6CCOCC6)(C4)C5)c(C4COC4)n3)cc21.Cc1cc(-c2cn(C34CC(C3)C4)c([C@H](C)O)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CCCO3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cc1C(F)(F)F
InChIInChI=1S/C24H28N4O2.C23H27F3N4O.C22H29N5O2.2C22H29N5O.C21H27N5O.C16H20N4O/c1-16-2-3-20-19(16)8-17(9-25-20)21-10-28(22(26-21)18-11-30-12-18)24-13-23(14-24,15-24)27-4-6-29-7-5-27;1-15-18(23(24,25)26)9-17(10-27-15)19-11-30(20(28-19)8-16-2-3-16)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-15-9-16(10-24-19(15)23)17-11-27(20(25-17)18-3-2-6-29-18)22-12-21(13-22,14-22)26-4-7-28-8-5-26;2*1-15-8-17(10-24-20(15)23)18-11-27(19(25-18)9-16-2-3-16)22-12-21(13-22,14-22)26-4-6-28-7-5-26;1-14-8-16(9-23-18(14)22)17-10-26(19(24-17)15-2-3-15)21-11-20(12-21,13-21)25-4-6-27-7-5-25;1-9-3-12(7-18-14(9)17)13-8-20(15(19-13)10(2)21)16-4-11(5-16)6-16/h2,8-10,18H,3-7,11-15H2,1H3;9-11,16H,2-8,12-14H2,1H3;9-11,18H,2-8,12-14H2,1H3,(H2,23,24);2*8,10-11,16H,2-7,9,12-14H2,1H3,(H2,23,24);8-10,15H,2-7,11-13H2,1H3,(H2,22,23);3,7-8,10-11,21H,4-6H2,1-2H3,(H2,17,18)/t;;;;;;10-,11?,16?/m......0/s1
InChIKeyOBJCYQFASQQPOK-BHGHLZHYSA-N
MW2641.37 g/mol
LogP20.40
Rot. Bonds30

About (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine

(1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine (PubChem CID 159944945) has the molecular formula C150H189F3N32O9 and a molecular weight of 2641.37 g/mol. Its IUPAC name is (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine.

Molecular Properties

Compound Name(1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine
PubChem CID159944945
Molecular FormulaC150H189F3N32O9
Molecular Weight2641.37 g/mol
Exact Mass2639.53
IUPAC Name(1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine
SMILESCC1=CCc2ncc(-c3cn(C45CC(N6CCOCC6)(C4)C5)c(C4COC4)n3)cc21.Cc1cc(-c2cn(C34CC(C3)C4)c([C@H](C)O)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CCCO3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cc1C(F)(F)F
InChIInChI=1S/C24H28N4O2.C23H27F3N4O.C22H29N5O2.2C22H29N5O.C21H27N5O.C16H20N4O/c1-16-2-3-20-19(16)8-17(9-25-20)21-10-28(22(26-21)18-11-30-12-18)24-13-23(14-24,15-24)27-4-6-29-7-5-27;1-15-18(23(24,25)26)9-17(10-27-15)19-11-30(20(28-19)8-16-2-3-16)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-15-9-16(10-24-19(15)23)17-11-27(20(25-17)18-3-2-6-29-18)22-12-21(13-22,14-22)26-4-7-28-8-5-26;2*1-15-8-17(10-24-20(15)23)18-11-27(19(25-18)9-16-2-3-16)22-12-21(13-22,14-22)26-4-6-28-7-5-26;1-14-8-16(9-23-18(14)22)17-10-26(19(24-17)15-2-3-15)21-11-20(12-21,13-21)25-4-6-27-7-5-25;1-9-3-12(7-18-14(9)17)13-8-20(15(19-13)10(2)21)16-4-11(5-16)6-16/h2,8-10,18H,3-7,11-15H2,1H3;9-11,16H,2-8,12-14H2,1H3;9-11,18H,2-8,12-14H2,1H3,(H2,23,24);2*8,10-11,16H,2-7,9,12-14H2,1H3,(H2,23,24);8-10,15H,2-7,11-13H2,1H3,(H2,22,23);3,7-8,10-11,21H,4-6H2,1-2H3,(H2,17,18)/t;;;;;;10-,11?,16?/m......0/s1
InChIKeyOBJCYQFASQQPOK-BHGHLZHYSA-N
XLogP20.40
TPSA458.58 Ų
H-Bond Donors6
H-Bond Acceptors41
Rotatable Bonds30
Heavy Atoms194
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002641.37
LogP ≤ 520.40
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1041

Analyze (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine?
The IUPAC name of (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine (CID 159944945) is (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine.
What is the SMILES notation for (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine?
The canonical SMILES for (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine is CC1=CCc2ncc(-c3cn(C45CC(N6CCOCC6)(C4)C5)c(C4COC4)n3)cc21.Cc1cc(-c2cn(C34CC(C3)C4)c([C@H](C)O)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CCCO3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC3CC3)n2)cc1C(F)(F)F.
What is the InChIKey of (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine?
The InChIKey is OBJCYQFASQQPOK-BHGHLZHYSA-N. The full InChI is InChI=1S/C24H28N4O2.C23H27F3N4O.C22H29N5O2.2C22H29N5O.C21H27N5O.C16H20N4O/c1-16-2-3-20-19(16)8-17(9-25-20)21-10-28(22(26-21)18-11-30-12-18)24-13-23(14-24,15-24)27-4-6-29-7-5-27;1-15-18(23(24,25)26)9-17(10-27-15)19-11-30(20(28-19)8-16-2-3-16)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-15-9-16(10-24-19(15)23)17-11-27(20(25-17)18-3-2-6-29-18)22-12-21(13-22,14-22)26-4-7-28-8-5-26;2*1-15-8-17(10-24-20(15)23)18-11-27(19(25-18)9-16-2-3-16)22-12-21(13-22,14-22)26-4-6-28-7-5-26;1-14-8-16(9-23-18(14)22)17-10-26(19(24-17)15-2-3-15)21-11-20(12-21,13-21)25-4-6-27-7-5-25;1-9-3-12(7-18-14(9)17)13-8-20(15(19-13)10(2)21)16-4-11(5-16)6-16/h2,8-10,18H,3-7,11-15H2,1H3;9-11,16H,2-8,12-14H2,1H3;9-11,18H,2-8,12-14H2,1H3,(H2,23,24);2*8,10-11,16H,2-7,9,12-14H2,1H3,(H2,23,24);8-10,15H,2-7,11-13H2,1H3,(H2,22,23);3,7-8,10-11,21H,4-6H2,1-2H3,(H2,17,18)/t;;;;;;10-,11?,16?/m......0/s1.
What are the key properties of (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine?
(1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine has a molecular weight of 2641.37 g/mol, XLogP of 20.40, 30 rotatable bonds, 6 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for (1S)-1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol;4-[3-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-(cyclopropylmethyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;4-[3-[4-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-2-(oxetan-3-yl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;3-methyl-5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-(oxolan-2-yl)imidazol-4-yl]pyridin-2-amine is sourced from PubChem (CID 159944945), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).